Home/Filings/3/0001104659-25-097621
3//SEC Filing

BEB Holdings, LLC 3

Accession 0001104659-25-097621

CIK 0002023016other

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 7:08 PM ET

Size

14.7 KB

Accession

0001104659-25-097621

Insider Transaction Report

Form 3
Period: 2025-10-07
Holdings
  • Common Stock

    (indirect: By LLC)
    16,016,260
Burnam Bradley Evan
DirectorChief Executive Officer10% Owner
Holdings
  • Common Stock

    (indirect: By LLC)
    16,016,260
Footnotes (2)
  • [F1]The number of shares of common stock reported gives effect to the 2-for-1 forward stock split that took effect on September 30, 2025.
  • [F2]Represents shares of common stock held by BEB Holdings, LLC. The reporting person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. Accordingly, all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person.

Issuer

Turn Therapeutics Inc.

CIK 0002023016

Entity typeother
IncorporatedGA

Related Parties

1
  • filerCIK 0002087363

Filing Metadata

Form type
3
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 7:08 PM ET
Size
14.7 KB